How is QR678® different from Stem Cell Treatments for hair loss?
Stem cell therapy is one of the evolving approaches explored for treating hair loss, including conditions like androgenetic alopecia and alopecia areata. There are several types of stem cells that can be used in hair loss treatment, including mesenchymal stem cells (MSCs), adipose-derived stem cells, and hair follicle stem cells. These stem cells can be harvested from various sources, such as adipose tissue (fat), bone marrow, or even the patient’s own scalp.
Stem cells are believed to promote hair growth by releasing growth factors and cytokines that stimulate existing hair follicles and encourage the growth of new ones. They can help reduce inflammation in the scalp and enhance the health and functionality of hair follicles, leading to stronger hair. The mechanism by which stem cells promote hair growth is not entirely understood, and research in this area continues.
Stem cells can be harvested from the patient’s own body, typically from adipose tissue or bone marrow. Alternatively, stem cells can be obtained from a donor. The harvesting and processing of stem cells for hair loss treatment require specialized medical expertise. The harvested stem cells are then processed to concentrate and purify them. Stem cells can be injected into the scalp or applied topically. In some cases, they may be combined with other treatments like platelet-rich plasma (PRP).
The safety and efficacy of stem cell therapy for hair loss are still under investigation, and the field is still evolving. It’s important to seek treatment from reputable, qualified medical professionals who adhere to ethical and regulatory guidelines.
Stem cell therapy for hair loss is generally considered safer when using the patient’s own cells to reduce the risk of immune rejection or other complications. However, the treatment may not be suitable for all individuals, and results can vary based on factors like the underlying cause of hair loss and the patient’s overall health.
Shortcomings Of The Stem Cell Therapy
- The field is still evolving and is not backed by substantial evidence in the form of research studies and clinical trials
- Low survival rates of stem cells post-extraction
- Chances of microbial contamination of stem cells might result in complications
- Based on the specific application, SC should be differentiated into appropriate cell types before they can be clinically used, failure of which may have deleterious effects
What is QR678®?
The QR678 research & development platform technology is a proprietary first-in-class technology. This science backed technology is giving rise to multiple products that arrest hair fall and address the thickness, density of hair follicles leading to greater coverage in hair loss. This R&D technology deals with multiple human hair growth related growth factors that are naturally present in our scalp making products derived from these completely natural. Research on this platform technology has resulted in this being awarded USA & Indian patents and has led to over 13+ clinical research papers being published with products derived from this unique technology. The hair growth factors penetrate deep into the scalp and provide nourishment to the scale. Unlike other treatments that contains harmful medication, products derived from QR678 are almost completely devoid of side effects.
How is QR678® different from Stem Cell Therapy?
| QR678® | Stem Cell Therapy |
| Standardized solutions – method & frequency of administration, dosage, etc. | No standardization |
| Specific concentration of biomimetic peptides | |
| Robust clinical data on safety and efficacy | Unreliable and methodically inadequate data |
| Targeted solutions – only hair growth specific factors in the right concentration | Multipurpose and non hair specific |
| Clinical evidence in – Androgenetic Alopecia, Alopecia Areata, Chemotherapy Induced Alopecia, Telogen Effluvium | Lack of valid evidence |
| Easy and quick to use | Cumbersome and longer procedure |
| No inhibitory growth factors | Some inhibitory factors + |
| No investment in device etc | Investment for devices + |
| Negligible side effects | Painful, higher incidence of side effects |
| Patented products, regulatory approved in 10+ countries | No regulatory approvals |